Condition
Post COVID-19 Condition (PCC)
Total Trials
5
Recruiting
3
Active
3
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 85/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
50.0%
-36.6% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Recruiting3
Completed1
Terminated1
Trial Success Rate
50.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05781893CompletedPrimary
Basel Long COVID-19 Cohort Study and Digital Long COVID Substudy
NCT07278206Not ApplicableRecruiting
Brain Stimulation in Long COVID
NCT07110714Not ApplicableRecruiting
Effects of Kneipp Hydrotherapy in Post-COVID-19 Patients
NCT06776263RecruitingPrimary
Dysfunctional Breathing in Post COVID-19 Condition.
NCT06113679Not ApplicableTerminatedPrimary
Pilot Randomized Study of RD-X19 Tx Device in Subjects With PCC (Long Covid) in the Outpatient Setting
Showing all 5 trials